Abdullah A Yousef

Dr. Abdullah A Yousef

Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
+1
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 1998 in Cerebrovascular Diseases
Verified
Journal Article
Closed access
PDF file
SASaad Al-Rajeh
Saad Al-Rajeh
ELEmmanuel B. Larbi
Emmanuel B. Larbi
OBOlajide Bademosi
Olajide Bademosi
AAAdnan Awada
Adnan Awada
Abdullah A YousefAbdullah A Yousef
Abdullah A Yousef
HMHani Miniawi
Hani Miniawi
A stroke registry was established in the Eastern Province of Saudi Arabia with an estimated population of 750,000 inhabitants of whom 545,000 are Saudi citizens. The register started in July 1989 and ended in July 1993. The Gulf war led to its interruption from August 1990 to August 1991. Four hundred eighty-eight cases (314 males, 174 females) of first-ever strokes affecting Saudi nationals were registered over the 3-year period. The crude incidence rate for first-ever strokes was 29.8/100,000/year (95% CI: 25.2–34.3/100,000 year). When standardized to the 1976 US population, it rose up to 125.8/100,000/year. Ischemic strokes (69%) predominated as in other studies but subarachnoid hemorrhage (SAH) was extremely rare (1.4%). The important risk factors were: systemic hypertension (38%), diabetes mellitus (37%), heart disease (27%), smoking (19%) and family history of stroke (14%). Previous transient ischemic attacks (3%) and carotid bruits (1%) were uncommon. The 30-day case fatality rate was 15%. The study showed that the age-adjusted stroke incidence rate for Saudis in this region is lower than the rates reported in developed countries but within the range reported worldwide. The pattern of stroke in Saudi Arabia is not different from that reported in other communities with the exception of the low incidence of SAH. The risk factors are similar to findings in other studies except for the high frequency of diabetes mellitus in our cases. The lower mortality rate was probably due to the younger age of the population and the availability of free medical services for management of cases.

23 January 2014 in BMC Public Health
Verified
Journal Article
Open access
PDF file
AAArwa Alumran
Arwa Alumran
XHXiang-Yu Hou
Xiang-Yu Hou
JSJiandong Sun
Jiandong Sun
Abdullah A YousefAbdullah A Yousef
Abdullah A Yousef
CHCameron Hurst
Cameron Hurst
Background: The overuse of antibiotics is becoming an increasing concern. Antibiotic resistance, which increases both the burden of disease, and the cost of health services, is perhaps the most profound impact of antibiotics overuse. Attempts have been made to develop instruments to measure the psychosocial constructs underlying antibiotics use, however, none of these instruments have undergone thorough psychometric validation. This study evaluates the psychometric properties of the Parental Perceptions on Antibiotics (PAPA) scales. The PAPA scales attempt to measure the factors influencing parental use of antibiotics in children. Methods: 1111 parents of children younger than 12 years old were recruited from primary schools’ parental meetings in the Eastern Province of Saudi Arabia from September 2012 to January 2013. The structure of the PAPA instrument was validated using Confirmatory Factor Analysis (CFA) with measurement model fit evaluated using the raw and scaled χ 2, Goodness of Fit Index, and Root Mean Square Error of Approximation. Results: A five-factor model was confirmed with the model showing good fit. Constructs in the model include: Knowledge and Beliefs, Behaviors, Sources of information, Adherence, and Awareness about antibiotics resistance. The instrument was shown to have good internal consistency, and good discriminant and convergent validity. Conclusion: The availability of an instrument able to measure the psychosocial factors underlying antibiotics usage allows the risk factors underlying antibiotic use and overuse to now be investigated.

1 January 2019 in Annals of Thoracic Medicine
Verified
Journal Article
Open access
PDF file
MAMohamed S Al-Moamary
Mohamed S Al-Moamary
SASamiA Alhaider
SamiA Alhaider
AAAbdullahA Alangari
AbdullahA Alangari
MGMohammedO Al Ghobain
MohammedO Al Ghobain
MZMohammedO Zeitouni
MohammedO Zeitouni
MAMohamed S Al-Hajjaj
Mohamed S Al-Hajjaj
This is the fourth version of the updated guidelines for the diagnosis and management of asthma, developed by the Saudi Initiative for Asthma (SINA) group, a subsidiary of the Saudi Thoracic Society. The main objective of the SINA is to have guidelines that are up to date, simple to understand, and easy to use by healthcare workers dealing with asthma patients. To facilitate achieving the goals of asthma management, the SINA panel approach is mainly based on the assessment of symptom control and risk for both adults and children. The approach to asthma management is now more aligned for different age groups. The guidelines have focused more on personalized approaches reflecting better understanding of disease heterogeneity with integration of recommendations related to biologic agents, evidence-based updates on treatment, and role of immunotherapy in management. The medication appendix has also been updated with the addition of recent evidence, new indications for existing medication, and new medications. The guidelines are constructed based on the available evidence, local literature, and current situation at national and regional levels. There is also an emphasis on patient–doctor partnership in the management that also includes a self-management plan.

1 January 2016 in Annals of Thoracic Medicine
Verified
Journal Article
Open access
PDF file
MAMohamed S Al-Moamary
Mohamed S Al-Moamary
SASamiA Alhaider
SamiA Alhaider
MIMajdy M Idrees
Majdy M Idrees
MGMohammedO Al Ghobain
MohammedO Al Ghobain
MZMohammedO Zeitouni
MohammedO Zeitouni
MAMohamed S Al-Hajjaj
Mohamed S Al-Hajjaj
This is an updated guideline for the diagnosis and management of asthma, developed by the Saudi Initiative for Asthma (SINA) group, a subsidiary of the Saudi Thoracic Society. The main objective of SINA is to have guidelines that are up to date, simple to understand and easy to use by nonasthma specialists, including primary care and general practice physicians. SINA approach is mainly based on symptom control and assessment of risk as it is the ultimate goal of treatment. The new SINA guidelines include updates of acute and chronic asthma management, with more emphasis on the use of asthma control in the management of asthma in adults and children, inclusion of a new medication appendix, and keeping consistency on the management at different age groups. The section on asthma in children is rewritten and expanded where the approach is stratified based on the age. The guidelines are constructed based on the available evidence, local literature, and the current situation in Saudi Arabia. There is also an emphasis on patient–doctor partnership in the management that also includes a self-management plan.

1 December 2013 in Emerging Infectious Diseases
Verified
Journal Article
Open access
SGStefanie Gierer
Stefanie Gierer
HHHeike Hofmann-Winkler
Heike Hofmann-Winkler
WAWaleed H. Albuali
Waleed H. Albuali
SBStephanie Bertram
Stephanie Bertram
AAAbdullah M. Al-Rubaish
Abdullah M. Al-Rubaish
Stefan PöhlmannStefan Pöhlmann
Stefan Pöhlmann
We used a lentiviral vector bearing the viral spike protein to detect neutralizing antibodies against Middle East respiratory syndrome coronavirus (MERS-CoV) in persons from the Eastern Province of Saudi Arabia. None of the 268 samples tested displayed neutralizing activity, which suggests that MERS-CoV infections in humans are infrequent in this province.

1 June 2010 in Paediatric Respiratory Reviews
Verified
Journal Article
Closed access
Abdullah A YousefAbdullah A Yousef
Abdullah A Yousef
AJAdam Jaffe
Adam Jaffe